Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients

Bone Marrow Transplantation

Volumn 36, Issue 6, 2005, Pages 481-489

  Bochennek, K ^a   Andreas, C ^a   Margraf, C ^a   Stahlkamp, H ^a   Zimmermann, S ^a   Esser, R ^a   Schwabe, D ^a   Klingebiel, T ^a   Gruttner H P ^a   Koehl, U ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Autologous stem cell transplantation; CD34 monitoring; Children; Mobilization of CD34 positive cells

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOPOTECAN; VINCRISTINE; VINDESINE;

ADOLESCENT; ANTIGEN DETECTION; APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD SAMPLING; CANCER COMBINATION CHEMOTHERAPY; CELL MOTILITY; CHILD; CHILD CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; KINETICS; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 31044445174     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705098     Document Type: Article

References (39)

1. Gale RP, Henon P, Juttmer C. Blood stem cell transplants come of age. Bone Marrow Transplant 1992; 9: 151-157.
2. Leibundgut K, Hirt A, Luthy AR et al. Autotransplants with peripheral blood stem cells and clinical results obtained in children: A review. Eur J Pediatr 1993; 152: 546-554.
3. Diaz MA, Vincent M, Garcia-Sanchez F et al. Long term hematopoietic engraftment after autologous peripheral blood progenitor cell transplantation in pediatric patients: Effect of the CD34+ cell dose. Vox Sanguinis 2000; 79: 145-150.
4. Handgretinger R, Lang P, Ihm K et al. Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: Purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant 2002; 29: 731-736.
5. Armitage S, Hargreaves R, Samson D et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Bone Marrow Transplant 1998; 22: 215-216.
6. Demirer T, Ilhan O, Ayli M et al. Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield. Therapeut Apheresis 2002; 6: 384-389.
7. Fontao-Wendel R, Lazar A, Melges S et al. The absolute number of circulating CD34+ cells is the best predictor of peripheral hematopoietic stem cell yield. J Hematother 1999; 8: 255-262.
8. Locatelli F, Perotti C, Zecca M, Pedrazzoli P. Transplantation of peripheral blood stem cells mobilized by haematopoietic growth factors in childhood. Bone Marrow Transplant 1998; 22 (Suppl. 2): S51-S55.
9. Remes K, Matinlauri I, Grenman S et al. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery. Hematotherapy 1997; 6: 13-19.
10. Urashima M, Kato Y, Hoshi Y et al. Factors affecting the efficiency of peripheral blood stem cell collection in children treated with chemotherapy and G-CSF. Acta Paediatr Jpn 1994; 36: 156-161.
11. Yu J, Leisenring W, Bensinger WI, Holmberg LA. The predictive value of white cell or CD34+ cell count in the peripheral blood for timing of apheresis and maximizing yield. Transfusion 1999; 39: 442-450.
12. Kasparu H, Krieger O, Girschikofsky M et al. Factors influencing the timing of peripheral blood stem cell collection (PBSC). Transfus Sci 1996; 17: 595-600.
13. Knudsen LM, Gaarsdal E, Jensen L et al. Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells. J Hematother 1996; 5: 399-406.
14. To LB, Shepperd M, Haylock DN et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 1990; 18: 442-447.
15. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Onc 1995; 13: 2547-2555.
16. Weaver CH, Birch R, Greco FA, Schwartzberg L. Mobilization and harvesting of peripheral blood stem cells: Randomized evaluations of different doses of filgrastim. Br J Haemat 1998; 100: 338-347.
17. Demeocq F, Kanold J, Chassagne J et al. Successful blood stem cell collection and transplantation in children weighing less than 25 kg. Bone Marrow Transplant 1994; 13: 45-50.
18. Fischmeister G, Kurz M, Haas OA et al. G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBSC) and leukocytes in healthy volunteers: Comparison of efficacy and tolerability. Ann Hematol 1999; 78: 117-123.
19. Lydaki E, Bolonaki E, Stiakaki E et al. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies. Pediatr Hematol Oncol 1995; 12: 551-558.
20. Diaz MA, Villa M, Allegre A et al. Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancies. Br J Haematol 1996; 96: 148-154.
21. Smolowicz AG, Villman K, Berlin G, Tidefelt U. Kinetics of peripheral blood stem cell harvests during a single apheresis. Transfusion 1999; 39: 403-409.
22. Dreger P, Schmitz N. Stem cell mobilization in healthy donors: Current status. Infus Ther Transf Med 1999; 26: 92-95.
23. Jilma B, Hergovich N, Stohlawetz P et al. Circadian variation of granulocyte colony stimulating factor levels in man. Br J Haematol 1999; 106: 368-370.
24. Abrahamsen JF, SmSaaland R, Sothern RB, Laerum OD. Variation in cell yield and proliferative activity of positive selected human CD34+ bone marrow cells along the circadian time scale. Eur J Haematol 1998; 60: 7-15.
25. Kiefer T, Kalusche EM, Schüler F, Hutzschenreuter U. Circadian variations of circulating CD34+ cell numbers after chemotherapy plus G-CSF in patients with breast cancer. Onkologie 1997; 20: 344, abstract (DÖGHO).
26. Köchling G, Legat D, Weber BE et al. Circadian variations of CD34+ cell-concentrations following mobilization with chemotherapy and filgrastim. Onkologie 1997; 20: 343; abstract (DÖGHO).
27. Sato N, Sawada K, Takahashi TA et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp Hematol 1994; 22: 973-978.
28. Sekhsaria S, Fleisher TA, Vowells S et al. Granulocyte colony-stimulating factor recruitment of CD34+ progenitors to peripheral blood: Impaired mobilization in chronic granulomatous disease and adenosine deaminase-deficient severe combined immunodeficiency disease patients. Blood 1996; 88: 1104-1112.
29. Stroncek DF, Clay ME, Herr G et al. The kinetics of G-CSF mobilization of CD34+ cells in healthy people. Transf Med 1997; 7: 19-24.
30. Watts MJ, Addison I, Ings SJ, Long SG. Optimal timing for collection of PBPC after glycosylated G-CSF administration. Bone Marrow Transplant 1998; 21: 365-368.
31. Fischer J, Unkrig U, Ackermann M, Frick M. Intra-day CD34+ cell counts depend on the timing to administration and correlate with the resulting G-CSF plasma level after steady-state mobilization of PBPC by filgrastim. Blood 1994; 84: 81; abstract (ASH).
32. Bjarnson GA, Reis M, Robinson JB et al. Circadian variation in CD34+ count and response to G-CSF therapy in healthy volunteers: Implication for harvesting efficacy. Blood 1996; 87: 1568; abstract #368-III (ASH).
33. Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 1996; 5: 213-225.
34. Moretti S, Dabusti M, Castagnari B et al. Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: Correlation with colony assay. Int J Biol Markers 2002; 17: 259-267.
35. Barbosa IL, Sousa ME, Godinho MI et al. Single- versus dual-platform assays for human CD34+ cell enumeration. Cytometry 1999; 38: 274-279.
36. Lefrere F, Bernard M, Audat F, Cavazzana-Calvo M. Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: A retrospective study of 126 patients. Leuk Lymphoma 1999; 35: 501-505.
37. 2) after salvage chemotherapy for lymphoma. Bone Marrow Transplant 1997; 20: 855-858.
38. Arbona C, Prosper F, Benet I, Mena F. Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells in normal donors for allogenic PBPC transplantation. Bone Marrow Transplant 1998; 22: 39-45.
39. Kröger N, Zeller W, Hassan TH, Krüger W. Schedule-dependency of G-CSF in peripheral blood progenitor cell mobilization in breast cancer patients. Blood 1998; 91: 828-830.